Completed Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT03676101 Conditions AIS, CIN 3, CIN1, +46 more Locations Zhejiang Provincial Center for Disease Control and Prevention — Hanzhou, China View Trial Details
Completed Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women NCT01366742 Conditions CIN 2, CIN 3, Human Papillomavirus Locations SFSU Student Health Center — San Francisco, California, United States HPV Study - San Leandro Office — San Leandro, California, United States View Trial Details